SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-025781
Filing Date
2023-09-13
Accepted
2023-09-13 16:30:50
Documents
14
Period of Report
2023-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20230913_8k.htm   iXBRL 8-K 27664
2 EXHIBIT 99.1 ex_569456.htm EX-99.1 12181
  Complete submission text file 0001437749-23-025781.txt   165339

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arch-20230913.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230913_def.xml EX-101.DEF 10353
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230913_lab.xml EX-101.LAB 13836
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230913_pre.xml EX-101.PRE 10348
8 EXTRACTED XBRL INSTANCE DOCUMENT arch20230913_8k_htm.xml XML 2322
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 231253045
SIC: 3841 Surgical & Medical Instruments & Apparatus